Evidence map›Paper›PMID 38221785›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2024

Palindromic carbazole derivatives: unveiling their antiproliferative effect via topoisomerase II catalytic inhibition and apoptosis induction.

Mateusz Olszewski, Natalia Maciejewska, Anoop Kallingal, Agnieszka Chylewska, Aleksandra M Dąbrowska, Małgorzata Biedulska, Mariusz Makowski, José M Padrón, Maciej Baginski

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Synthesis,Journal of enzyme inhibition and medicinal chemistry · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Mateusz OlszewskiDepartment of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, Gdansk, Poland.ORCID 0000-0002-1952-4985
Natalia MaciejewskaDepartment of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, Gdansk, Poland.
Anoop KallingalDepartment of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, Gdansk, Poland.
Agnieszka ChylewskaDepartment of Bioinorganic Chemistry, Faculty of Chemistry, University of Gdansk, Gdansk, Poland.
Aleksandra M DąbrowskaDepartment of Bioinorganic Chemistry, Faculty of Chemistry, University of Gdansk, Gdansk, Poland.
Małgorzata BiedulskaDepartment of Bioinorganic Chemistry, Faculty of Chemistry, University of Gdansk, Gdansk, Poland.
Mariusz MakowskiDepartment of Bioinorganic Chemistry, Faculty of Chemistry, University of Gdansk, Gdansk, Poland.ORCID 0000-0002-7342-722X
José M PadrónBioLab, Instituto Universitario de Bio-Orgánica "Antonio González", Universidad de La Laguna, La Laguna, Spain.
Maciej BaginskiDepartment of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, Gdansk, Poland.ORCID 0000-0002-6795-7515
Gdańsk University of Technology · PLUniversity of Gdańsk · PLUniversidad de La Laguna · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human DNA topoisomerases are essential for crucial cellular processes, including DNA replication, transcription, chromatin condensation, and maintenance of its structure. One of the significant strategies employed in cancer treatment involves the inhibition of a specific type of topoisomerase, known as topoisomerase II (Topo II). Carbazole derivatives, recognised for their varied biological activities, have recently become a significant focus in oncological research. This study assesses the efficacy of three symmetrically substituted carbazole derivatives: 2,7-Di(2-furyl)-9H-carbazole (

Indexed as

Antineoplastic AgentsTopoisomerase II InhibitorsApoptosisCarbazolesDNA Topoisomerases, Type IIHumansAntineoplastic AgentscarbazoleCarbazolesDNA Topoisomerases, Type IITopoisomerase II InhibitorsApoptosiscancercarbazoletopoisomerase

Identifiers

PMID38221785
PMCPMC10791108
OpenAlexW4390883699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.